{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:39Z","timestamp":1791389199180,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["No.202300410467"],"award-info":[{"award-number":["No.202300410467"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Projects of Medical Science and Technology in Henan Province of China","award":["No. SBGJ2020002053"],"award-info":[{"award-number":["No. SBGJ2020002053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent studies about the effect of gonadotropin (Gn) dose on the clinical outcomes of IVF are still controversial, and no studies have analyzed the relationship between Gn dose and embryo quality. Since AMH is a strong predictor of oocyte quality, we aim to evaluate the relationship between total Gn dose and embryo quality and clinical outcomes at different AMH levels in IVF cycles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 12,588 patients were enrolled in the retrospective study. The included cycles were categorized by serum AMH levels (AMH\u2009\u2264\u20091\u00a0ng\/ml, 1\u00a0ng\/ml\u2009&lt;\u2009AMH\u2009\u2264\u20093\u00a0ng\/ml, 3\u00a0ng\/ml\u2009&lt;\u2009AMH\u2009\u2264\u20095\u00a0ng\/ml, AMH\u2009&gt;\u20095\u00a0ng\/ml), total Gn dosage (&lt;\u20091875\u00a0IU, 1875\u20133750\u00a0IU and\u2009\u2265\u20093750\u00a0IU) and female age (&lt;\u200935\u00a0years and 35\u201342\u00a0years). The embryo quality and clinical outcomes were the measure outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The top-day3 embryos rate decreased with the increase of total Gn dose in nearly all age and AMH subgroups, but this trend was not obvious in the AMH\u2009&gt;\u20095\u00a0ng\/ml group and AMH\u2009\u2264\u20091\u00a0ng\/ml group. The blastocyst formation rate and high-quality blastulation rate had a negative relationship with Gn does for women aged\u2009&lt;\u200935\u00a0years in the AMH\u2009\u2264\u20095\u00a0ng\/ml groups, except for the AMH\u2009&gt;\u20095\u00a0ng\/ml group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). However, when women were 35\u201342\u00a0years old, regardless of AMH levels, the blastocyst formation rate and high-quality blastulation rate decreased as Gn dose increased. Clinical outcomes (implantation rate, clinical pregnancy rate and live birth rate) decreased with the increase of Gn dose in all ages and AMH stratifications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The total dose of Gn may have different effects on embryo quality at different serum AMH levels, and the negative effects of total dose of Gn on clinical outcomes may be realized by impairing both embryo quality and endometrium.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-024-01768-w","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T06:43:33Z","timestamp":1710225813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of total gonadotropin dose on embryo quality and clinical outcomes with AMH stratification in IVF cycles: a retrospective analysis of 12,588 patients"],"prefix":"10.1186","volume":"29","author":[{"given":"Xiaoxue","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1768_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1210\/er.2005-0015","volume":"27","author":"NS Macklon","year":"2006","unstructured":"Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The science behind 25 Years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170\u2013207.","journal-title":"Endocr Rev"},{"key":"1768_CR2","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768\u201374.","journal-title":"Hum Reprod"},{"key":"1768_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967\u201373.","journal-title":"Fertil Steril"},{"key":"1768_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/humrep\/des389","volume":"28","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod. 2013;28:442\u201352.","journal-title":"Hum Reprod"},{"key":"1768_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.fertnstert.2020.10.059","volume":"115","author":"O Ishihara","year":"2021","unstructured":"Ishihara O, Klein BM, Arce J-C, Kuramoto T, Yokota Y, Mukaida T, et al. Randomized, assessor-blind, antim\u00fcllerian hormone\u2013stratified, dose-response trial in Japanese in vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta. Fertil Steril. 2021;115:1478\u201386.","journal-title":"Fertil Steril"},{"key":"1768_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.fertnstert.2018.05.024","volume":"110","author":"KS Acharya","year":"2018","unstructured":"Acharya KS, Acharya CR, Bishop K, Harris B, Raburn D, Muasher SJ. Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry. Fertil Steril. 2018;110:880\u20137.","journal-title":"Fertil Steril"},{"key":"1768_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","volume":"104","author":"VL Baker","year":"2015","unstructured":"Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104:1145-1152.e5.","journal-title":"Fertil Steril"},{"key":"1768_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tjog.2019.05.007","volume":"58","author":"Y-C Yang","year":"2019","unstructured":"Yang Y-C, Li Y-P, Pan S-P, Chao K-H, Chang C-H, Yang J-H, et al. The different impact of stimulation duration on oocyte maturation and pregnancy outcome in fresh cycles with GnRH antagonist protocol in poor responders and normal responders. Taiwan J Obstet Gynecol. 2019;58:471\u20136.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1768_CR9","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/dex299","volume":"32","author":"OO Barash","year":"2017","unstructured":"Barash OO, Hinckley MD, Rosenbluth EM, Ivani KA, Weckstein LN. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer. Hum Reprod. 2017;32:2209\u201317.","journal-title":"Hum Reprod"},{"key":"1768_CR10","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/humrep\/deaa028","volume":"35","author":"M Irani","year":"2020","unstructured":"Irani M, Canon C, Robles A, Maddy B, Gunnala V, Qin X, et al. No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies. Hum Reprod. 2020;35:1082\u20139.","journal-title":"Hum Reprod"},{"key":"1768_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0890-6238(92)90196-Z","volume":"6","author":"R Vogel","year":"1992","unstructured":"Vogel R, Spielmann H. Genotoxic and embryotoxic effects of gonadotropin-hyperstimulated ovulation of murine oocytes, preimplantation embryos, and term fetuses. Reprod Toxicol. 1992;6:329\u201333.","journal-title":"Reprod Toxicol"},{"key":"1768_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.fertnstert.2004.09.039","volume":"83","author":"ST Lee","year":"2005","unstructured":"Lee ST, Kim TM, Cho MY, Moon SY, Han JY, Lim JM. Development of a hamster superovulation program and adverse effects of gonadotropins on microfilament formation during oocyte development. Fertil Steril. 2005;83:1264\u201374.","journal-title":"Fertil Steril"},{"key":"1768_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1095\/biolreprod.104.032003","volume":"72","author":"R Roberts","year":"2005","unstructured":"Roberts R, Iatropoulou A, Ciantar D, Stark J, Becker DL, Franks S, et al. Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro1. Biol Reprod. 2005;72:107\u201318.","journal-title":"Biol Reprod"},{"key":"1768_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/humrep\/16.6.1237","volume":"16","author":"I Van der Auwera","year":"2001","unstructured":"Van der Auwera I. Superovulation of female mice delays embryonic and fetal development. Hum Reprod. 2001;16:1237\u201343.","journal-title":"Hum Reprod"},{"key":"1768_CR15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/humrep\/del484","volume":"22","author":"EB Baart","year":"2007","unstructured":"Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NGM, Verhoeff A, et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22:980\u20138.","journal-title":"Hum Reprod"},{"key":"1768_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1089\/gtmb.2018.0063","volume":"22","author":"K Sachdeva","year":"2018","unstructured":"Sachdeva K, Upadhyay D, Discutido R, Varghese MM, Albuz F, Almekosh R, et al. Low gonadotropin dosage reduces aneuploidy in human preimplantation embryos: first clinical study in a UAE population. Genet Test Mol Biomarkers. 2018;22:630\u20134.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1768_CR17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/humrep\/den269","volume":"23","author":"W Verpoest","year":"2008","unstructured":"Verpoest W, Fauser BC, Papanikolaou E, Staessen C, Van Landuyt L, Donoso P, et al. Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. Hum Reprod. 2008;23:2369\u201371.","journal-title":"Hum Reprod"},{"key":"1768_CR18","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.fertnstert.2010.07.1088","volume":"95","author":"JAM Massie","year":"2011","unstructured":"Massie JAM, Shahine LK, Milki AA, Westphal LM, Lathi RB. Ovarian stimulation and the risk of aneuploid conceptions. Fertil Steril. 2011;95:970\u20132.","journal-title":"Fertil Steril"},{"key":"1768_CR19","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/humrep\/der318","volume":"26","author":"AN Andersen","year":"2011","unstructured":"Andersen AN, Witjes H, Gordon K, Mannaerts B, on behalf of the Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Human Reprod. 2011;26:3413\u201323.","journal-title":"Human Reprod"},{"key":"1768_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmm034","volume":"14","author":"BCJM Fauser","year":"2008","unstructured":"Fauser BCJM, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14:1\u201314.","journal-title":"Hum Reprod Update"},{"key":"1768_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17:46\u201354.","journal-title":"Hum Reprod Update"},{"key":"1768_CR22","volume-title":"A textbook of in vitro fertilization and assisted reproduction","author":"P Brinsden","year":"1999","unstructured":"Brinsden P. A textbook of in vitro fertilization and assisted reproduction. New York: The Parthenon Publishing Group Inc; 1999."},{"key":"1768_CR23","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/j.fertnstert.2019.08.077","volume":"112","author":"DK Gardner","year":"2019","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Reprint of: blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2019;112:e81\u20134.","journal-title":"Fertil Steril"},{"key":"1768_CR24","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/humrep\/der182","volume":"26","author":"AP Yates","year":"2011","unstructured":"Yates AP, Rustamov O, Roberts SA, Lim HYN, Pemberton PW, Smith A, et al. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod. 2011;26:2353\u201362.","journal-title":"Hum Reprod"},{"key":"1768_CR25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00404-013-3132-1","volume":"289","author":"B Vural","year":"2014","unstructured":"Vural B, Cakiroglu Y, Vural F, Filiz S. Hormonal and functional biomarkers in ovarian response. Arch Gynecol Obstet. 2014;289:1355\u201361.","journal-title":"Arch Gynecol Obstet"},{"key":"1768_CR26","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/humrep\/deh508","volume":"19","author":"A La Marca","year":"2004","unstructured":"La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti-M\u00fcllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod. 2004;19:2738\u201341.","journal-title":"Hum Reprod"},{"key":"1768_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ijgo.12941","volume":"147","author":"E Azizi","year":"2019","unstructured":"Azizi E, Naji M, Nazari L, Salehpour S, Karimi M, Borumandnia N, et al. Serum anti-M\u00fcllerian hormone is associated with oocyte dysmorphisms and ICSI outcomes. Int J Gynecol Obstet. 2019;147:179\u201386.","journal-title":"Int J Gynecol Obstet"},{"key":"1768_CR28","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"J-C Arce","year":"2013","unstructured":"Arce J-C, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99:1644-1653.e1.","journal-title":"Fertil Steril"},{"key":"1768_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","volume":"31","author":"P Lehmann","year":"2014","unstructured":"Lehmann P, V\u00e9lez MP, Saumet J, Lapens\u00e9e L, Jamal W, Bissonnette F, et al. Anti-M\u00fcllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 2014;31:493\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"1768_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1262\/jrd.2020-102","volume":"67","author":"M Fushii","year":"2021","unstructured":"Fushii M, Yamada R, Miyano T. In vitro growth of bovine oocytes in oocyte-cumulus cell complexes and the effect of follicle stimulating hormone on the growth of oocytes. J Reprod Dev. 2021;67:5\u201313.","journal-title":"J Reprod Dev"},{"key":"1768_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1071\/RD11079","volume":"23","author":"S Liu","year":"2011","unstructured":"Liu S, Feng HL, Marchesi D, Chen Z-J, Hershlag A. Dose-dependent effects of gonadotropin on oocyte developmental competence and apoptosis. Reprod Fertil Dev. 2011;23:990.","journal-title":"Reprod Fertil Dev"},{"key":"1768_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1071\/RD13024","volume":"26","author":"X Wang","year":"2014","unstructured":"Wang X, Tsai T, Qiao J, Zhang Z, Feng HL. Impact of gonadotropins on oocyte maturation, fertilisation and developmental competence in vitro. Reprod Fertil Dev. 2014;26:752.","journal-title":"Reprod Fertil Dev"},{"key":"1768_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.fertnstert.2008.07.006","volume":"92","author":"A Demirol","year":"2009","unstructured":"Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril. 2009;92:481\u20135.","journal-title":"Fertil Steril"},{"key":"1768_CR34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0015-0282(97)00409-3","volume":"68","author":"MA Aboulghar","year":"1997","unstructured":"Aboulghar MA, Mansour RT, Serour GI, Ramzy AM, Amin YM. Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertil Steril. 1997;68:1017\u201321.","journal-title":"Fertil Steril"},{"key":"1768_CR35","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(05)66478-1","volume":"365","author":"BC Fauser","year":"2005","unstructured":"Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. The Lancet. 2005;365:1807\u201316.","journal-title":"The Lancet"},{"key":"1768_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.fertnstert.2005.03.045","volume":"84","author":"MG Katz-Jaffe","year":"2005","unstructured":"Katz-Jaffe MG, Trounson AO, Cram DS. Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions. Fertil Steril. 2005;84:634\u201343.","journal-title":"Fertil Steril"},{"key":"1768_CR37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10815-017-0909-3","volume":"34","author":"L Sekhon","year":"2017","unstructured":"Sekhon L, Shaia K, Santistevan A, Cohn KH, Lee JA, Beim PY, et al. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response. J Assist Reprod Genet. 2017;34:749\u201358.","journal-title":"J Assist Reprod Genet"},{"key":"1768_CR38","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/humrep\/dex094","volume":"32","author":"EM Munch","year":"2017","unstructured":"Munch EM, Sparks AE, Zimmerman MB, Van Voorhis BJ, Duran EH. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers. Hum Reprod. 2017;32:1402\u20139.","journal-title":"Hum Reprod"},{"key":"1768_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tjog.2009.08.003","volume":"50","author":"C-C Chang","year":"2011","unstructured":"Chang C-C, Hsieh Y-Y, Hsu K-H, Lin C-S. Effects of gonadotropins (Gonal-F and Puregon) on human endometrial cell proliferation in vitro. Taiwan J Obstet Gynecol. 2011;50:42\u20137.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1768_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012693.pub2","author":"SF Lensen","year":"2018","unstructured":"Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI). Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD012693.pub2.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-01768-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:09:09Z","timestamp":1710493749000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-01768-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-01768-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Reference: 2021-KY-0223-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}